2Negro G,Krzysztofiak A,Bartamamm V.Canciclovir therapy for cytomegalous associated liver disease in immunocopetent or immunocompromised children[J].Archvirol,2002,142(3):573.
二级参考文献1
1G. Nigro,A. Krzysztofiak,U. Bartmann,A. Clerico,E. Properzi,S. Valia,M. Castello. Ganciclovir therapy for cytomegalovirus-associated liver disease in immunocompetent or immunocompromised children[J] 1997,Archives of Virology(3):573～580
5Yao QQ, Dong XL, Wang XC, et al. Hepatitis B virus surface antigen ( HBsAg)-positive and HBsAg negative hepatitis B virus in{ection among mother teenager pairs 13 years after neonatal hepatitis B virus vaccination. Clin Vaccine Immunol, 2013, 20: 269-275.
6FH Su, CH Bai, FY Chu,et al. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan. Vaccine, 2012, 30 : 4034-4039.
7Kianifar HR, Tehranian S, Shojaei P, et al. Accuracy of hepatobiliary scintigraphy for differentiation of neonatal hepatitis from biliary atresia: systematic review and recta-analysis of the literature. Pediatric Radiology, 2013, 43 : 905 -919.
